Redcare Pharmacy’s Digital Prescription Revolution Fuels Record Growth
Published on 10/07/2025 at 17:54 | Redaktion boerse-global.de
Germany’s transition to digital prescriptions is proving to be a powerful catalyst for Redcare Pharmacy, with the MDAX-listed company reporting exceptional third-quarter performance that significantly outpaces competitors in the online pharmacy sector. Revenue surged by 25% to reach €719 million, demonstrating robust expansion despite challenging market conditions. The critical question facing investors is whether this operational momentum can reverse the stock’s persistent downward trajectory.
The unexpected departure of CFO Jasper Eenhorst in late September has been managed without disrupting the company’s strategic direction. CEO Olaf Heinrich has assumed interim responsibility for financial operations while the supervisory board actively searches for a permanent replacement. Heinrich expressed confidence in the company’s trajectory, stating, “Our growth remains both profitable and cash-generating.”
Management... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
